Previous studies have reported that novel STAT3 inhibitors such as atovaquone, SC99, and LLL12 can kill STAT3-active MM cells and significantly suppress subcutaneous tumors in SCID-mouse xenograft models [33,34,35]. Here, STAT3 is linked to Miyoshi myopathy.